(Q44754538)
Statements
Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level (English)
David Nolan
Emma Hammond
Ian James
Elizabeth McKinnon
1 December 2003